This page includes the latest FDA filings for Acerus Pharmaceuticals Corp. Currently, you will find the latest 100 filings for Premarket Notifications, Premarket Applications, De Novo Applications, and GUDID registrations.
| CANADA | TORONTO STOCK EXCHANGE | ASP | DUNS 243912362 | 
| Device Company | Device | Date | 
|---|---|---|
| Acerus Pharmaceuticals Corporation | Prescription Medication | 2025-07-26 | 
| Acerus Pharmaceuticals Corporation | Prescription Medication | 2025-04-03 | 
| Acerus Pharmaceuticals Corporation | Prescription Medication | 2022-12-20 | 
| Acerus Pharmaceuticals Corporation | Prescription Medication | 2021-12-23 | 
| Acerus Pharmaceuticals Corporation | Prescription Medication | 2020-11-14 | 
| Acerus Pharmaceuticals Corporation | Prescription Medication | 2020-05-21 | 
| Acerus Pharmaceuticals Corporation | Prescription Medication | 2020-05-19 | 
| Acerus Pharmaceuticals Corporation | Prescription Medication | 2020-05-16 | 
| Acerus Pharmaceuticals Corporation | Prescription Medication | 2020-05-15 | 
| Acerus Pharmaceuticals Corporation | Natesto | 2020-05-08 | 
| NCAGE Code | L0MW0 | ACERUS PHARMACEUTICALS CORPORATION | 
| SEC | 0001527246 | Acerus Pharmaceuticals Corp of ONTARIO, CANADA |